API Manufacturing Facility
cGMP facility for API manufacturing spread over 39 acres
	USFDA approved; EU-GMP targeted Monthly capacity of 10 to 12 tons, with Pharma grade powder processing facility. Dedicated API block for manufacturing Cytotoxic APIs An Intermediate block for enhanced output A separate Iron compound block
Reaction Capabilities
	Amidation Grignard Hydrogenation Polymerisation Phosgenation Reduction Chiral resolutions Halogenation
Key Plant Features
	Multipurpose. Flexible: Various unit operations being performed. Batch size : 2 kg to 250 kg. Operating pressure : Full vacuum to atmospheric . Operating temperature : - 30°C to 150°C . Hydrogenation capability: 630 & 1500 L capacity, up to 30 kg pressure and 130°C temperature.
Cytotoxic API Manufacturing Facility
	Multipurpose plant designed for highly potent APIs using isolator based technology Reactors ranging from 100 to 1000 Liters Flexible batch sizes ranging from 2 to 25 kg. Manufacturing capacity of 1000 kg/ annum Modular plant with provision for further expansion Facility operational (5 USDMFs filed, many more underway)
R&D Capabilities: API
	Team of > 228 including 6 Post-doc fellows, 12 Ph.D.’s and 81 PG scientists Synthetic chemistry skills for: Selectively identified Chiral APIs (have launched # of chiral molecules in India) Molecule identification to development Developing APIs for global markets Peptide synthesis Multi-purpose R&D-cum-pilot scale production facility Focus on Anticancer, Haematinics, Cardiovascular and Anti-Retro Viral drugs